3,3'-Diethyloxacarbocyanine iodide

Names

[ CAS No. ]:
905-96-4

[ Name ]:
3,3'-Diethyloxacarbocyanine iodide

[Synonym ]:
G 1745
MFCD00011952
DOC Iodide
(2Z)-3-ethyl-2-[(E)-3-(3-ethyl-1,3-benzoxazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzoxazole,iodide
3,3'-dietyl oxacarbocyanine iodide
EINECS 212-996-6

Biological Activity

[Description]:

3,3'-Diethyloxacarbocyanine iodide is a microviscosity probe for micelles and microemulsions[1].

[Related Catalog]:

Research Areas >> Others

Signaling Pathways >> Others >> Others

[References]

[1]. SaswatiBasu, et al. 3,3′-Diethyloxacarbocyanine iodide: A new microviscosity probe for micelles and microemulsions. Colloids and Surfaces A: Physicochemical and Engineering Aspects.

[2]. E L Sievers, et al. Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood. 1999 Jun 1;93(11):3678-84.

Chemical & Physical Properties

[ Melting Point ]:
278ºC (dec.)(lit.)

[ Molecular Formula ]:
C₂₁H₂₁IN₂O₂

[ Molecular Weight ]:
460.31

[ Exact Mass ]:
460.06500

[ PSA ]:
35.09000

[ LogP ]:
1.08680

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
26-36

[ RIDADR ]:
NONH for all modes of transport

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Articles

TLR signaling modulates side effects of anticancer therapy in the small intestine.

J. Immunol. 194(4) , 1983-95, (2015)

Intestinal mucositis represents the most common complication of intensive chemotherapy, which has a severe adverse impact on quality of life of cancer patients. However, the precise pathophysiology re...

Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.

Sci. Rep. 5 , 16887, (2015)

Mutant huntingtin (mHtt) aggregation in the nucleus is the most readily apparent phenotype and cause of neuronal death in Huntington's disease (HD). Inhibiting mHtt aggregation reduces cell death in t...

Structure-activity relationship of cyanine tau aggregation inhibitors.

J. Med. Chem. 52 , 3539-47, (2009)

A structure-activity relationship for symmetrical cyanine inhibitors of human tau aggregation was elaborated using a filter trap assay. Antagonist activity depended on cyanine heterocycle, polymethine...